Buprenorphine is one of the most effective medications for treating opioid use disorder (OUD), but it comes in several very different forms: a buprenorphine injection vs. sublingual films/tablets. While all of them work by stabilizing opioid receptors and reducing withdrawal and cravings, they vary in:
- How they’re absorbed
- How long they last
- How often they’re taken
- Their misuse or diversion potential
- Their suitability based on individual recovery needs
Understanding the differences helps patients and providers choose the safest and most effective option for long-term recovery.
How Buprenorphine Works
Buprenorphine is a partial opioid agonist, meaning:
- It reduces cravings and withdrawal
- It produces a “ceiling effect,” lowering overdose risk
- It blocks full opioids (heroin, fentanyl, oxycodone) from attaching to receptors
All formulations share this same mechanism, but how the medication enters the bloodstream changes its effectiveness and consistency.
Buprenorphine Sublingual (Under-the-Tongue Tablets/Films)
(Suboxone®, Subutex®, generics)
Sublingual buprenorphine is the most widely used outpatient MAT option.
How Sublingual Buprenorphine is Taken
Placed under the tongue or inside the cheek until dissolved—absorbed through oral mucosa, not swallowed.
Pros
- Works quickly (20–45 minutes)
- Flexible dosing adjustments
- Widely available
- Often combined with naloxone to deter misuse
Cons
- Must be taken daily
- Requires consistency, missed doses = withdrawal
- Potential diversion or misuse
- Bitter taste; some struggle with dissolution time
Who Sublingual Buprenorphine is Best For
Individuals who can take medication consistently and prefer a self-administered MAT option with strong evidence and flexibility.
Buprenorphine Injection (Extended-Release Depot Injections)
(Brixadi®, Sublocade®)
Injectable buprenorphine has become one of the most important MAT advancements. These formulations deliver medication slowly and steadily over a week or month.
How Injectable Buprenorphine is Given
- Administered by a medical provider
- Injected into subcutaneous tissue
- Medication forms a depot that releases over time
Pros
- No daily dosing → eliminates missed doses
- Dramatically lower diversion/misuse risk
- Stable blood levels → fewer peaks and withdrawals
- Ideal for people who struggle with consistency or have severe cravings
- Reduced stigma (no take-home medication)
Cons
- Must visit a clinic regularly
- Not suitable for people who fear injections
- Requires people to be stabilized on sublingual first
- Skin irritation is possible
Who Injectable Buprenorphine is Best For
Those who want long-acting stability, accountability, and reduced cravings, especially individuals who had difficulty with daily sublingual dosing.
Buprenorphine Injection vs. Sublingual: Comparison Table
| Feature | Buprenorphine Injection | Buprenorphine Sublingual |
|---|---|---|
| How It’s Taken | Weekly or monthly injection by a clinician | Daily film or tablet dissolved under the tongue / in cheek |
| Onset of Action | Slow, steady release over days | Onset within 20–45 minutes |
| Dosing Frequency | Weekly or monthly (no daily dosing) | Once daily (sometimes twice) |
| Stability of Blood Levels | Very stable; minimal peaks/withdrawals | Levels can fluctuate more due to daily dosing |
| Risk of Misuse/Diversion | Extremely low (clinic-administered only) | Moderate (take-home medication) |
| Ideal For | People who struggle with consistency, have relapse risk, or prefer no take-home medication | People who want flexible dosing or are starting buprenorphine for induction |
| Privacy/Stigma Considerations | No pill bottles at home; discreet | Must keep medication secure; some stigma around Suboxone |
| Common Barriers | Requires clinic visits; needle aversion | Must remember daily dosing; potential diversion |
| Need to Be Stabilized First? | Yes—usually requires days of sublingual induction | No—used directly for induction |
| Insurance Coverage | Generally covered, but may require prior authorization | Widely covered and available |
Which Form of Buprenorphine Works Best?
There is no universal answer. It depends on:
- Lifestyle
Daily medication vs. monthly injections. - Risk of relapse
Injectable forms provide steady levels with no missed doses. - Misuse/diversion risk
Injections eliminate this nearly completely. - How quickly symptoms need relief
Sublingual is faster at onset. - Treatment setting
Residential programs may prefer injectable formulations.
Most experts recommend starting with sublingual buprenorphine, then transitioning to weekly or monthly injections once withdrawal and cravings are stabilized.
When Injectable Buprenorphine May Be the Safer Choice
Injectable buprenorphine is often recommended when someone:
- Has repeated relapses
- Struggles to take medication consistently
- Experiences cravings even on stable doses
- Misuses or diverts sublingual meds
- Wants a discreet, no-take-home option
- Lives in a home where medication security is a concern
For many people, long-acting injection becomes the “set it and forget it” version of MAT that supports stable, long-term recovery.
Conclusion
All forms of buprenorphine help treat opioid use disorder, but they differ in convenience, stability, and misuse risk:
- Sublingual = flexible, fast, self-administered
- Injection = long-acting stability, minimal misuse risk, improved adherence
The best choice depends on the individual’s recovery needs, history, and lifestyle, not a one-size-fits-all approach. Brooks Healing Center offers Medication-Assisted Treatment within our Medical Detox and Residential Treatment programs. Call today for an assessment to determine which of these medications are right for your recovery needs.
Frequently Asked Questions
How does injectable buprenorphine work compared to daily Suboxone?
Injectable buprenorphine releases medication slowly and consistently over a week or month, creating stable blood levels without the peaks and dips associated with daily sublingual dosing. Suboxone works well for many people, but injections reduce missed doses and remove the risk of diversion.
How long do buprenorphine injections stay in your system?
Weekly formulations typically last 7 days, while monthly injections can remain active for 28–35 days. Residual medication may stay in the body longer because extended-release depots dissolve gradually.
Can you switch from Suboxone to injectable buprenorphine?
Yes. Most people begin with sublingual buprenorphine for stabilization and then transition to weekly or monthly injections once their dose is steady. The process is coordinated by a prescribing clinician.
Are buprenorphine injections stronger than sublingual films?
Not necessarily stronger, but more stable. Injections prevent sudden drops in blood levels, which may reduce cravings and help people who struggle with daily adherence.
Who is a good candidate for injectable buprenorphine?
People who miss daily doses, desire more privacy, have persistent cravings, or have difficulty managing take-home medications often benefit from weekly or monthly injections.
Do buprenorphine injections show up differently on a drug test?
No. Drug tests detect the metabolite norbuprenorphine, not the route of administration. Whether taken sublingually or by injection, the results appear the same.
Can injectable buprenorphine be misused?
No. Because injections are administered in a clinic and cannot be taken home, they essentially eliminate the diversion and misuse risks associated with some take-home medications.
Sources
- U.S. Food & Drug Administration. (2024). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud
- National Institute on Drug Abuse. (2024). Medications to treat opioid use disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
- Substance Abuse and Mental Health Services Administration. (2024). Medications for substance use disorders. https://www.samhsa.gov/substance-use/treatment/options
- Substance Abuse and Mental Health Services Administration. (2023). Opioid treatment programs (OTPs). https://www.samhsa.gov/medications-substance-use-disorders/otp
- Centers for Disease Control and Prevention. (2024). Using medications to treat opioid use disorder. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/medications-for-opioid-use-disorder.html
- Shulman, M., Wai, J. M., & Nunes, E. V. (2019). Buprenorphine treatment for opioid use disorder: An overview. Addiction Science & Clinical Practice, 14(44). https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-019-0160-
- American Society of Addiction Medicine. (2020). National practice guideline for the treatment of opioid use disorder. https://www.asam.org/quality-care/clinical-guidelines
- U.S. Food & Drug Administration. (2023). Brixadi (buprenorphine extended-release injection). https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/brixadi-buprenorphine
